Rytary Side Effects: What to Expect and When to Call Your Doctor

Rytary (carbidopa and levodopa extended-release capsules) is an effective treatment for Parkinson's disease, but like all medications, it comes with a range of potential side effects. Some are mild and often temporary; others are serious and require immediate medical attention.

This guide walks through the most important Rytary side effects — what they feel like, how common they are, how to manage them, and when to call your doctor. Always discuss side effects with your neurologist before making any changes to your dose or schedule.

Common Side Effects of Rytary

These side effects are reported frequently in clinical trials and patient experience. They are often manageable and may improve over time as your body adjusts.

Nausea: One of the most commonly reported side effects when starting Rytary, especially during the dose escalation period. Taking your dose with a small snack (but avoiding high-fat, high-calorie meals that slow absorption) can help. Carbidopa in Rytary helps reduce nausea compared to levodopa alone, but some nausea may still occur.

Dizziness and lightheadedness: Often related to orthostatic hypotension (a drop in blood pressure when standing up). Rise slowly from seated or lying positions. Stay well hydrated.

Headache: Reported in some patients, typically mild and often resolving with continued use.

Dry mouth: Sipping water frequently and using sugar-free gum or lozenges can help. Good dental hygiene is important with chronic dry mouth.

Insomnia and abnormal dreams: Some patients report difficulty sleeping or vivid, abnormal dreams. Discuss with your neurologist if sleep is significantly affected — dose timing adjustments may help.

Dark-colored urine, saliva, or sweat: Levodopa can cause urine, saliva, or sweat to turn red, black, or dark brown. This is harmless but can stain clothing. Report to your doctor if you're unsure whether it's from Rytary or another cause.

Dyskinesia: The Most Common Serious Side Effect

Dyskinesia — involuntary, uncontrolled movements — is among the most clinically significant side effects of Rytary and of levodopa therapy in general. It typically appears after years of levodopa treatment, not immediately. Dyskinesia can manifest as writhing, wriggling, or jerky movements of the arms, legs, torso, or head.

If dyskinesia develops, your neurologist may adjust your Rytary dose, change dosing frequency, add amantadine (Gocovri), or reassess your overall treatment regimen. Do not reduce your Rytary dose on your own.

Serious Side Effects: Call Your Doctor Immediately

These side effects require prompt medical evaluation:

Hallucinations or psychosis: In clinical trials of advanced Parkinson's patients, 4% of Rytary-treated patients reported hallucinations compared to 1% on IR carbidopa-levodopa. These include seeing or hearing things that aren't there, paranoid thoughts, confusion, or agitation. Contact your neurologist if you or a caregiver notices these symptoms.

Sudden sleep attacks: Levodopa can cause sudden, uncontrolled onset of sleep — sometimes with no warning drowsiness. Do not drive or operate heavy machinery until you know how Rytary affects you. Tell your doctor if you notice new or excessive sleepiness.

Orthostatic hypotension (severe): Significant drops in blood pressure upon standing that cause fainting or near-fainting. Report to your doctor, especially if you're on other blood pressure medications.

Neuroleptic malignant syndrome (NMS): A rare but life-threatening reaction that can occur if Rytary is suddenly stopped. Symptoms include high fever, severe muscle stiffness, sweating, fast heartbeat, and confusion. Seek emergency care immediately if these occur after dose reduction or discontinuation.

Impulse control disorders: Some patients develop compulsive behaviors including pathological gambling, hypersexuality, compulsive eating, or compulsive spending. Inform your doctor if any new compulsive urges develop.

Vitamin B6 deficiency and seizures: Carbidopa-levodopa therapy can deplete vitamin B6 levels. The FDA has issued guidance requiring vitamin B6 monitoring. Seizures associated with B6 deficiency have been reported. Have your B6 levels checked and supplement as directed.

Cardiovascular ischemic events: Chest pain, shortness of breath, or symptoms of heart attack or stroke require emergency care. Rytary clinical trials noted a slightly higher rate of cardiovascular ischemic events in patients with pre-existing heart disease or risk factors.

Managing Side Effects: General Tips

Take the first dose of the day 1–2 hours before eating to optimize absorption; subsequent doses can be taken with a light snack.

Avoid high-fat, high-calorie meals at the time of dosing — they delay levodopa absorption by up to 2 hours.

Space iron supplements and multivitamins containing iron at least 2 hours away from Rytary — iron interferes with levodopa absorption.

Keep a diary of your 'on' and 'off' periods and any side effects to share with your neurologist at appointments.

The Bottom Line

Most Rytary patients tolerate it well, especially once the dose is dialed in by their neurologist. The key is to communicate side effects promptly rather than quietly tolerating them or, worse, stopping the medication on your own. Also be sure to review our guide to Rytary drug interactions — certain medications and foods can significantly affect how well Rytary works or increase the risk of adverse effects.